Other languages Aileron Therapeutics, Inc.

Equities

ALRN

US00887A2042

Market Closed - Nasdaq Other stock markets 02:00:00 07/05/2024 am IST			5-day change	1st Jan Change
3.95 ^USD	+5.05%		-19.72%	+29.57%

03/05	Aileron Therapeutics Closes Direct Offering of Shares, Warrants	MT
01/05	Transcript : Aileron Therapeutics, Inc. - Special Call

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aileron Therapeutics Closes Direct Offering of Shares, Warrants	04/05
Aileron Therapeutics, Inc. Announces Positive Data from Cohort 1 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis	01/05
Aileron Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Aileron Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	16/04
Aileron Therapeutics, Inc. Announces Board Changes	29/03
Aileron Therapeutics Names Brian Windsor as CEO	12/03
Aileron Therapeutics, Inc. Announces Appointment of Brian Windsor as President and to the Board of Directors	12/03
Aileron Therapeutics, Inc. Announces CEO Changes	12/03
Aileron Therapeutics, Inc. Announces Resignation of Nolan Sigal, M.D., Ph.D. from Board of Directors, Member of Nominating and Corporate Governance Committee	02/03
Aileron Therapeutics Acquires Lung Therapeutics in Stock-for-Stock Deal	31/23/31
Aileron Therapeutics, Inc. acquired Lung Therapeutics, Inc.	31/23/31
Aileron Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/23/14
Top Premarket Gainers	27/23/27
Aileron Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	12/23/12
Aileron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	08/23/08
Aileron Therapeutics, Inc. Auditor Raises 'Going Concern' Doubt	20/23/20
Sector Update: Health Care Stocks Edge Above Tuesday Intraday Lows	22/23/22
Sector Update: Health Care	22/23/22
Top Midday Decliners	22/23/22
Aileron Therapeutics to Halt Breast Cancer Trial, Development of ALRN-6924; Cut Workforce; Shares Plunge	21/23/21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Aileron Therapeutics, Inc.

Equities

ALRN

US00887A2042

Other languages

Filters